159 related articles for article (PubMed ID: 21432907)
1. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
Hahm ER; Lee J; Huang Y; Singh SV
Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
[TBL] [Abstract][Full Text] [Related]
2. Withaferin A-mediated apoptosis in breast cancer cells is associated with alterations in mitochondrial dynamics.
Sehrawat A; Samanta SK; Hahm ER; St Croix C; Watkins S; Singh SV
Mitochondrion; 2019 Jul; 47():282-293. PubMed ID: 30685490
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.
Sinha P; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485
[TBL] [Abstract][Full Text] [Related]
4. TNF alpha-induced down-regulation of estrogen receptor alpha in MCF-7 breast cancer cells.
Lee SH; Nam HS
Mol Cells; 2008 Sep; 26(3):285-90. PubMed ID: 18483465
[TBL] [Abstract][Full Text] [Related]
5. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
Royston KJ; Paul B; Nozell S; Rajbhandari R; Tollefsbol TO
Exp Cell Res; 2018 Jul; 368(1):67-74. PubMed ID: 29689276
[TBL] [Abstract][Full Text] [Related]
6. Withania somnifera inhibits photorefractoriness which triggers neuronal apoptosis in both pre-optic and paraventricular hypothalamic area of Coturnix coturnix japonica: involvement of oxidative stress induced p53 dependent Caspase-3 mediated low immunoreactivity of estrogen receptor alpha.
Baghel K; Niranjan MK; Srivastava R
Photochem Photobiol Sci; 2023 Sep; 22(9):2205-2218. PubMed ID: 37266906
[TBL] [Abstract][Full Text] [Related]
7. Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms.
Xing Z; Su A; Mi L; Zhang Y; He T; Qiu Y; Wei T; Li Z; Zhu J; Wu W
Drug Des Devel Ther; 2023; 17():2909-2929. PubMed ID: 37753228
[TBL] [Abstract][Full Text] [Related]
8. The Potential Pharmacological Effects of Natural Product Withaferin A in Cancer: Opportunities and Challenges for Clinical Translation.
Devabattula G; Panda B; Yadav R; Godugu C
Planta Med; 2024 May; 90(6):440-453. PubMed ID: 38588695
[TBL] [Abstract][Full Text] [Related]
9. Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.
Lee IC; Choi BY
Int J Mol Sci; 2016 Mar; 17(3):290. PubMed ID: 26959007
[TBL] [Abstract][Full Text] [Related]
10. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma.
Hassannia B; Wiernicki B; Ingold I; Qu F; Van Herck S; Tyurina YY; Bayır H; Abhari BA; Angeli JPF; Choi SM; Meul E; Heyninck K; Declerck K; Chirumamilla CS; Lahtela-Kakkonen M; Van Camp G; Krysko DV; Ekert PG; Fulda S; De Geest BG; Conrad M; Kagan VE; Vanden Berghe W; Vandenabeele P; Vanden Berghe T
J Clin Invest; 2018 Aug; 128(8):3341-3355. PubMed ID: 29939160
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A-Encapsulated PEGylated Nanoliposomes Induce Apoptosis in B16F10 Melanoma Cells by Regulating Bcl2 and Bcl xl Genes and Mitigates Murine Solid Tumor Development.
Abeesh P; Guruvayoorappan C
J Environ Pathol Toxicol Oncol; 2024; 43(2):29-42. PubMed ID: 38505911
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A and Celastrol Overwhelm Proteostasis.
Vilaboa N; Voellmy R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203539
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum antitumor properties of Withaferin A: a proteomic perspective.
Dom M; Vanden Berghe W; Van Ostade X
RSC Med Chem; 2020 Jan; 11(1):30-50. PubMed ID: 33479603
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives.
Behl T; Sharma A; Sharma L; Sehgal A; Zengin G; Brata R; Fratila O; Bungau S
Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33291236
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
Lee J; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
[TBL] [Abstract][Full Text] [Related]
16. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.
Hahm ER; Moura MB; Kelley EE; Van Houten B; Shiva S; Singh SV
PLoS One; 2011; 6(8):e23354. PubMed ID: 21853114
[TBL] [Abstract][Full Text] [Related]
17. Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice.
Khazal KF; Hill DL; Grubbs CJ
Anticancer Res; 2014 Nov; 34(11):6327-32. PubMed ID: 25368231
[TBL] [Abstract][Full Text] [Related]
18. Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomas.
Khazal KF; Samuel T; Hill DL; Grubbs CJ
Anticancer Res; 2013 Apr; 33(4):1519-23. PubMed ID: 23564793
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer.
Yadav DK; Kumar S; Saloni ; Singh H; Kim MH; Sharma P; Misra S; Khan F
Drug Des Devel Ther; 2017; 11():1859-1870. PubMed ID: 28694686
[TBL] [Abstract][Full Text] [Related]
20. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
Royston KJ; Udayakumar N; Lewis K; Tollefsbol TO
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
